Our company
Westlake Pharmaceuticals
We are an R&D driven biotech company spun off from Westlake University, committed to discovering and developing novel medicines.
Our founding team is led by Dr. Hongtao Yu, a world-renowned cell biologist and the Dean of the School of Life Sciences at Westlake University. The team also includes Westlake professors Dr. Qi Hu and Dr. Jing Huang, who expert in chemical biology and computational biophysics, respectively.
Supported by the research platforms at Westlake University and Westlake Laboratory, and through collaboration with partners, we are advancing the pipeline in oncology and infectious diseases.
Our Mission
Making therapeutic innovation benefit more patients
We are committed to discovering and developing first-in-class drugs.
Our Values
Patients First
Daring Innovation, Rigorous Truth-Seeking
Unite Across Boundaries
Advance as One
Our History
September 2020
Born in Yunqi Cloud Town, Hangzhou
September 2020
December 2020
Angel funding completed
December 2020
October 2020
Our first novel product Mprosevir approved by NMPA and FDA, advancing into clinical trials
October 2020
November 2022
A round funding completed
November 2022
September 2023
Phase III clinical trial of Mprosevir completed
September 2023
Our awards
Self-renewal driving innovation
